Advertisement
Ear/Nose/Throat
Subscribe to Ear/Nose/Throat
View Sample

FREE Email Newsletter

Starkey's AMP Wins Consumer Electronics Show Innovations 2012 Award

November 10, 2011 5:17 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Laboratories, Inc., one of the world's leading hearing technology companies, is excited to announce that it has been named an International CES Innovations 2012 Design and Engineering Awards Honoree for its AMPâ„¢ hearing aid.

AACR Releases Landmark Cancer Progress Report

September 20, 2011 5:35 am | by AACR | News | Comments

Tweet   Report Calls on Congress to Provide Critical Funding Increases for Life-saving Research Supported by the NIH and NCI WASHINGTON, D.C. — The American Association for Cancer Research will unveil the AACR Cancer Progress Report 2011 at 3:30 p.m. ET on Tuesday, Sept. 20,...

Edison Pharmaceuticals, Inc. Closes Financing

September 13, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Sept. 13, 2011 /- Edison Pharmaceuticals, Inc. announced today that it has closed a Series E Preferred Financing. Capital raised will fund US and European approval trials for the company's clinical candidates, EPI-A0001 and EPI-743. Terms of the financing were not...

Advertisement

ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers

September 8, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 8, 2011 /- ChromaDex® Corp. (OTCBB: CDXC) today announced that the University of California, Irvine has granted ChromaDex® the exclusive rights to a joint patent application filed by ChromaDex® and the university for the method of inducing...

American Animal Hospital Association and Heska Corporation Announce New Online Continuing Education Series

September 6, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

LOVELAND, Colo., Sept. 6, 2011 /- The American Animal Hospital Association (AAHA) and Heska Corporation (NASDAQ: HSKA ) are collaborating on a new series for online continuing education. Using the complexities and challenges of real-life examples, the "Solve It! Series"...

Prostate Cancer Awareness Month Starts in September

September 2, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

CORAL SPRINGS, Fla., Sept. 2, 2011 /- What do Robert DeNiro, Hugo Chavez, Rudy Giuliani, Roger Moore, John Kerry, Don Imus, Harry Belafonte, Nelson Mandela, Colin Powell, Frank Zappa, Telly Savalas, Bill Bixby and Timothy Leary all have in common? If your answer is prostate cancer, then...

Kimberly-Clark Health Care Announces Selling Price Increase

September 1, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., Sept. 1, 2011 /- Kimberly-Clark Health Care (KCHC) announced today that it is implementing a double-digit price increase on synthetic exam gloves due to unprecedented demand for and rising costs of raw materials, particularly butadiene and acrylonitrile.   "Despite...

New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population

September 1, 2011 12:36 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 1, 2011 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive.  The drug was approved based on data from two clinical...

Advertisement

MIT cites new approaches with microRNA testing

August 31, 2011 11:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Researchers at MIT say they have engineered a new method to detect abnormal microRNA levels in the blood of cancer patients, raising the possibility of developing a simple blood test to diagnose or monitor the disease.

IRIDEX Expands ENT Laser Applications

August 31, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Aug. 31, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) announced the introduction of its new XP Module - a high power factory installed option for the IRIDEX IQ 532 green laser system. The IQ 532 XP is a multifunctional device that can be utilized by both ear, nose...

The Pancreatic Cancer Action Network and AACR to Award More Than $3.1 Million in Pancreatic Cancer Research Grants

August 29, 2011 5:35 am | by AACR | News | Comments

Tweet Pancreatic Cancer Action Network-AACR Grants will Open for Applications on Sept. 1, 2011 PHILADELPHIA - The Pancreatic Cancer Action Network and the American Association for Cancer Research are pleased to announce the opening of the 2012 research grants program on Sept. 1, 2011. The...

LUNGevity Foundation Praises Recent FDA Approval of New Lung Cancer Treatment Drug XALKORI® (crizotinib)

August 27, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 27, 2011 /PRNewswire-USNewswire/ -- LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI® (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given...

B.U. to share in $19M breast cancer research grant

August 26, 2011 4:51 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston University will share in a $19.3 million grant to study racial disparities in breast cancer diagnosis and treatment.

Advertisement

Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System

August 22, 2011 3:52 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 22, 2011 /- Delcath Systems, Inc. (NASDAQ: DCTH ) reported encouraging top-line results from the hepatobiliary cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer. This study,...

Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator

August 17, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Former Congressman and PhRMA CEO Billy Tauzin has joined the board of the pharmaceutical benefits management company CaptureRx . He will also serve as the company's Chief Industry Relations Officer. Tauzin will work on behalf of...

The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face

August 17, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 17, 2011 /- The 14th annual Victory Over Diabetes event, hosted by the American Diabetes Association (the Association), will take place in Atlanta on August 20, featuring educational workshops, free health screenings and resources designed to encourage African Americans to...

FDA Proposes Guidelines That Clarify Benefit-Risk Determinations for Medical Devices

August 15, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Aug. 15, 2011 /PRNewswire-USNewswire/ -- For the first time, the U.S. Food and Drug Administration has provided draft guidance clarifying how benefit-risk determinations are made during premarket review of certain medical devices. (Logo:...

An Easier Test for TB

August 9, 2011 9:44 pm | by Massachusetts Institute of Technology | News | Comments

A study suggests that an electronic nose could sniff out tuberculosis in a urine sample.

PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis

August 4, 2011 5:46 am | by Bio-Medicine.Org | News | Comments

MONTGOMERYVILLE, Pa., Aug. 4, 2011 /- PhotoMedex , Inc. (NASDAQ: PHMD ), an innovator of medical devices, today launches a co-pay reimbursement offer*  to assist the families of children who suffer from psoriasis.  In honor of the National Psoriasis Awareness Month in August...

BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc.

August 2, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 2, 2011 /- Hadasit Bio-Holdings, Ltd. - (OTCBB: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, and its subsidiary, BioMarCare...

Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

ST. PAUL, Minn., Aug. 2, 2011 /- Apnex Medical, Inc., received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation (HGNS®) System to...

Siemens Partners with American Cancer Society to Make Strides Against Breast Cancer

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 2, 2011 /- Today, Siemens announced that it is partnering with the American Cancer Society (ACS) in support of its premier national event to fight breast cancer – Making Strides Against Breast Cancer. The company, a pioneer in the fields of industry, energy, and...

A Quick, Cheap Diagnostic Test for HIV and Other Infections

August 1, 2011 11:41 am | by Massachusetts Institute of Technology | News | Comments

A simple microfluidics chip could improve health care in poor countries by making rapid diagnostic testing a reality.

Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for Inadequate Leukemia and Cancer Warning

July 29, 2011 9:46 am | by Bio-Medicine.Org | News | Comments

DALLAS, July 29, 2011 /- Humira defect lawyers filed a lawsuit against Abbott Laboratories in Texas state court claiming Abbott's blockbuster drug, Humira, caused a life-threatening disease, leukemia. "Eleven year-old Bo Anderson was prescribed Humira for a skin condition, psoriasis....

Post Robotic Prostate Surgery Continence and Pelvic Floor Muscles

July 27, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 27, 2011 /- For men facing radical prostatectomy procedures, elimination of their prostate cancer is not their only concern. In fact, a large number of these men list damage to their sexual potency and urinary continence among their biggest fears. More than 240,000 men will...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading